Chemical Name:ABT-199

CAS No.: 1257044-40-8

Molecular formula: C45H50ClN7O7S

Molecular weight: 868.4392

Related Categories: Pharmaceutical Raw Materials;

Description:

ABT-199 is a new type of anticancer drug, a Bcl-2 inhibitor developed by the American pharmaceutical company AbbVie, which is effective against cancer and produces less than current drugs. The side effects of this study were mainly done by researchers in the United States and Australia, and the relevant research results were published in the international journal Nature Medicine.

Unlike ordinary cancer drugs, the drug named ABT-199 acts to treat cancer by attacking an important protein called BCL-2. BCL-2 is one of the first members of the BCL-2 protein family that regulate cell death. It is associated with many types of cancer, as well as some mental and autoimmune diseases. In cancer, it is thought to act as a suppressor that can help cancer cells fight cancer treatments.